Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Symptoms of the KP.3 COVID Variant, the New Dominant Strain
Prevention via Yahoo News· 6 days agoThe U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee...
Weekly COVID-19 cases up third straight week: Coronavirus update for Thursday, June 20, 2024
The Cleveland Plain Dealer· 4 days agoAt least 1,373,279 Ohioans have received the updated one-dose COVID-19 vaccine, an increase of 1,573...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 7 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 3 days agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
COVID summer wave grows, especially in West, with new variant LB.1 on the rise
CBS News· 2 days agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 3 days agoBooster shots improve immunity Pate urges people to stay up to date with COVID-19 vaccines. The...
France’s Macron, African leaders push for vaccines for Africa after COVID-19 exposed inequalities
CW39 NewsFix· 4 days agoPARIS (AP) — French President Emmanuel Macron is joining several African leaders on Thursday to kick...
BMJ study did not prove Covid-19 vaccines caused excess deaths
AFP via Yahoo News· 3 days agoArticles and social media posts claimed that research published in the British Medical Journal (BMJ)...
...Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1
NewMediaWire via Yahoo Finance· 6 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...